Changes in US stocks | Expectations for the acquisition of Lilai are heating up, and Abivax (ABVX.US) opens with a sharp rise approaching a record high

Zhitongcaijing · 3d ago

The Zhitong Finance App learned that on Monday, Abivax S.A. (ABVX.US) opened with a sharp rise of nearly 15%, approaching the previous record high, and is now reported at $131.59. According to the news, it is reported that Eli Lilly has begun preliminary discussions with the French authorities to explore a possible acquisition of biotech company Abivax. The report said that Eli Lilly held preliminary talks with the French Ministry of Finance in early December to assess whether the acquisition of Abivax would be restricted by the country's foreign investment review rules. According to reports, Eli Lilly also discussed the possible participation of state-owned investor Bpifrance as a minority shareholder.